Medtech businesses show tremendous potential for profitability and growth, triggering a sparked interest in investment.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Analysts expect 2020 to be a busy year for M&A activity.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.
Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.
Medical device companies have upped their game in product security and regulatory compliance, but they might not be ready for a catastrophic event.